Bladder Cancer - Results from #80

Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study. August 28, 2020

The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis. August 28, 2020

GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. August 27, 2020

Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications. August 27, 2020

Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer. August 27, 2020

[Analysis of self-control trial results of narrow band imaging and white light in transurethral resection of bladder tumor]. August 27, 2020

Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer. August 27, 2020

The Basal to Luminal Transition Classifier for Urothelial Cancer Subtypes - Expert Commentary August 26, 2020

Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index. August 26, 2020

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. August 26, 2020

Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size. August 26, 2020

Perioperative outcomes and safety of robotic vs open cystectomy: a systematic review and meta-analysis of 12,640 cases. August 26, 2020

Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma. August 25, 2020

Bladder perforation during transurethral resection of bladder tumour is not a result of a deficient structure of the bladder wall. August 25, 2020

Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument. August 25, 2020

Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States. August 25, 2020

Extra-Peritoneal versus Trans-Peritoneal Open Radical Cystectomy - Comparison of Two Techniques in Early Post-Operative Complications. August 25, 2020

Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. August 25, 2020

Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer. August 25, 2020

[Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection]. August 24, 2020

Page 5 of 362